Oral Bisoprolol for the treatment of non-resolving central serous chorioretinopathy: A case report

Vingolo EM, Napolitano G*, Rigoni E and De Rosa V

Purpose: To evaluate the effect of the beta blocker Bisoprolol in the treatment of chronic central serous chorioretinopathy (CSC).

Methods: Five patients with non-resolving CSC were treated with oral Bisoprolol 2,5 mg once a day for three months. The best-corrected visual acuity (BCVA), central macular thickness (CMT) and sub-retinal fluid (SRF) horizontal diameter recorded at baseline and at 1, 2, and 3 months by optical coherence tomography (OCT) were analyzed.

Results: All the patients achieved a full visual recovery after 3 months of treatment and there was no evidence of SRF at the last OCT follow-up. No side effect was recorded.

Conclusions: These results suggest that oral Bisoprolol may be effective in the treatment of chronic CSC and could be considered as a potential therapy choice in those cases at risk of diffuse retina pigment epitheliopathy.

Keywords:

Published on: Jun 12, 2020 Pages: 33-36

Full Text PDF Full Text HTML DOI: 10.17352/2455-1414.000070
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat